Merck & Co.Inc.Assessing The Value Of Linking Abstracted Medical Record Data With Administrative Claims Data To Study Patients With High-Risk Non-Muscle Invasive Bladder Cancer In The United StatesRead more →
2024 · Poster Presentation · Merck & Co. · Methods/PharmacoepiAssessing The Value Of Linking Abstracted Medical Record Data With Administrative Claims Data To Study Patients With High-Risk Non-Muscle Invasive Bladder Cancer In The United StatesRead more →